Pyxis Oncology Inc (PYXS) — Cash Flow-to-Debt Ratio
Latest as of September 2025:
-0.36x
Pyxis Oncology Inc (PYXS) has a Cash Flow-to-Debt Ratio of -0.36x as of September 2025, meaning its operating cash flow of $-13.28 Million could theoretically repay 0% of its total liabilities ($36.83 Million) in one year. See PYXS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.36x
Operating CF / Total Liabilities
Operating Cash Flow
$-13.28 Million
USD
Total Liabilities
$36.83 Million
USD
Data as of
Sep 2025
Most recent filing
Pyxis Oncology Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Pyxis Oncology Inc across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Pyxis Oncology Inc.
Annual Cash Flow-to-Debt Ratio for Pyxis Oncology Inc (2019–2024)
Year-by-year debt coverage analysis for Pyxis Oncology Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.58x | $-57.67 Million | $36.43 Million | ▼ -7.5% |
| 2023 | -1.47x | $-70.71 Million | $48.02 Million | ▲ +16.7% |
| 2022 | -1.77x | $-89.33 Million | $50.55 Million | ▲ +6.4% |
| 2021 | -1.89x | $-35.33 Million | $18.71 Million | ▼ -383.0% |
| 2020 | -0.39x | $-10.08 Million | $25.80 Million | ▼ -296.0% |
| 2019 | -0.10x | $-2.24 Million | $22.68 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.